中医药学报2026，Vol.54Issue(7)：56-60,5.DOI:10.19664/j.cnki.1002-2392.260141
泻肝止痛汤联合西药治疗肝经郁热型带状疱疹的疗效回顾分析
Retrospective Analysis of the Efficacy of Xiegan Zhitong Decoction Combined with Western Medicine in Treating Herpes Zoster with Liver Channel Stagnation-Heat Syndrome
摘要
Abstract
Objective:To investigate the efficacy and safety of Xiegan Zhitong Decoction combined with famciclovir tablets and mecobalamin tablets in treating herpes zoster with liver channel stagnation-heat syndrome.Methods:92 patients diagnosed with herpes zoster with liver channel stagnation-heat syndrome in the Department of Dermatology of Third Affiliated Hospital of Beijing University of Chinese Medicine from June 2022 to June 2024 were included.All patients received oral Xiegan Zhitong Decoction(1 dose/day,decocted in water)for one week as one treatment course,combined with famciclovir tablets for antiviral treatment and mecobalamin tablets for nerve nutrition.Clinical efficacy at different treatment courses,time-effect scores(time to stop blistering,crust formation time,crust shedding time,and pain relief time),pain and sleep scores,incidence of postherpetic neuralgia,and TCM syndrome scores were evaluated.Results:After treatment at each course,significant improvements were observed in time-effect scores,sleep and pain scores,and TCM syndrome scores(P<0.01,P<0.001).The cumulative effective rates at 1,2,3,and 4 weeks were 27.17%(25/92),88.04%(81/92),94.57%(87/92),and 98.91%(91/92)respectively.The incidence of postherpetic neuralgia was 1.09%(1/92).Conclusion:Xiegan Zhitong Decoction combined with famciclovir and mecobalamin tablets shows significant efficacy in treating herpes zoster with liver channel stagnation-heat syndrome,shortening recovery time,improving sleep,reducing pain,ameliorating TCM syndromes,with low incidence of postherpetic neuralgia and few adverse reactions.关键词
带状疱疹/肝经郁热证/泻肝止痛汤Key words
Herpes zoster/Liver channel stagnation-heat syndrome/Xiegan Zhitong Decoction分类
医药卫生引用本文复制引用
张莉莉,李林仙,范子怡,孙占学..泻肝止痛汤联合西药治疗肝经郁热型带状疱疹的疗效回顾分析[J].中医药学报,2026,54(7):56-60,5.基金项目
国家中医药管理局全国中医临床优秀人才研修项目(国中医药人教函[2022]1号) （国中医药人教函[2022]1号）
北京中医药大学"岐黄英才·名医培育计划"(Y2023A05) （Y2023A05）
